Literature DB >> 7718845

Silicotuberculosis: long-term outcome after short-course chemotherapy.

R L Cowie1.   

Abstract

SETTING: A medical facility for approximately 90,000 gold miners employed on 24 South African gold mines.
OBJECTIVE: To establish the long-term risk attributable to silicosis of relapse from pulmonary tuberculosis treated with short-course chemotherapy.
DESIGN: A consecutive sample of gold miners with pulmonary tuberculosis allocated to receive rifampicin, isoniazid, pyrazinamide and streptomycin given on weekdays for 5 months. Radiographs were assessed at the time of diagnosis for the presence of silicosis. All of the men were followed for at least 5 years after completing their treatment, or until they left mine service or suffered a relapse of tuberculosis.
RESULTS: The sample included 549 men of whom 167 had silicosis. The incidence density for relapse in silicosis was 1.55 (95% CI 0.97, 2.48) times that for the men without silicosis. There was no difference in the pattern of relapse over time between the two groups: the mean period to relapse in the men with silicosis was 2.6 years (SD 1.89 years) and for the men without silicosis was 3.1 years (SD 2.23 years) (P = 0.6).
CONCLUSION: Silicosis causes a small increase in the risk of relapse of tuberculosis. Relapses in both groups were not confined to the first 2 years after completion of treatment.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7718845     DOI: 10.1016/0962-8479(95)90578-2

Source DB:  PubMed          Journal:  Tuber Lung Dis        ISSN: 0962-8479


  2 in total

1.  Can treatment outcomes of latent TB infection and TB in silicosis be improved?

Authors:  Wing Wai Yew; Chi Chiu Leung; Kwok Chiu Chang; Ying Zhang; Denise P Chan
Journal:  J Thorac Dis       Date:  2019-01       Impact factor: 2.895

2.  Pulmonary tuberculoma and miliary tuberculosis in silicosis.

Authors:  Sanjeev Kumar Verma; Saurabh Karmakar
Journal:  J Clin Diagn Res       Date:  2013-02-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.